These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 23614975)

  • 1. Diffusion-weighted magnetic resonance imaging in the prostate transition zone: histopathological validation using magnetic resonance-guided biopsy specimens.
    Hoeks CM; Vos EK; Bomers JG; Barentsz JO; Hulsbergen-van de Kaa CA; Scheenen TW
    Invest Radiol; 2013 Oct; 48(10):693-701. PubMed ID: 23614975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of prostatitis and prostate cancer by using diffusion-weighted MR imaging and MR-guided biopsy at 3 T.
    Nagel KN; Schouten MG; Hambrock T; Litjens GJ; Hoeks CM; ten Haken B; Barentsz JO; Fütterer JJ
    Radiology; 2013 Apr; 267(1):164-72. PubMed ID: 23329653
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of diffusion-weighted MR imaging at inclusion in an active surveillance protocol for low-risk prostate cancer.
    Somford DM; Hoeks CM; Hulsbergen-van de Kaa CA; Hambrock T; Fütterer JJ; Witjes JA; Bangma CH; Vergunst H; Smits GA; Oddens JR; van Oort IM; Barentsz JO;
    Invest Radiol; 2013 Mar; 48(3):152-7. PubMed ID: 23328910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative Analysis of Diffusion Weighted Imaging May Improve Risk Stratification of Prostatic Transition Zone Lesions.
    Engel H; Oerther B; Reisert M; Kellner E; Sigle A; Gratzke C; Bronsert P; Krauss T; Bamberg F; Benndorf M
    In Vivo; 2022; 36(5):2323-2331. PubMed ID: 36099133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent diffusion coefficient values are superior to transrectal ultrasound-guided prostate biopsy for the assessment of prostate cancer aggressiveness.
    Li C; Chen M; Wang J; Wang X; Zhang W; Zhang C
    Acta Radiol; 2017 Feb; 58(2):232-239. PubMed ID: 27055916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR Fingerprinting and ADC Mapping for Characterization of Lesions in the Transition Zone of the Prostate Gland.
    Panda A; Obmann VC; Lo WC; Margevicius S; Jiang Y; Schluchter M; Patel IJ; Nakamoto D; Badve C; Griswold MA; Jaeger I; Ponsky LE; Gulani V
    Radiology; 2019 Sep; 292(3):685-694. PubMed ID: 31335285
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transition zone prostate cancer: detection and localization with 3-T multiparametric MR imaging.
    Hoeks CM; Hambrock T; Yakar D; Hulsbergen-van de Kaa CA; Feuth T; Witjes JA; Fütterer JJ; Barentsz JO
    Radiology; 2013 Jan; 266(1):207-17. PubMed ID: 23143029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solid bone tumors of the spine: Diagnostic performance of apparent diffusion coefficient measured using diffusion-weighted MRI using histology as a reference standard.
    Pozzi G; Albano D; Messina C; Angileri SA; Al-Mnayyis A; Galbusera F; Luzzati A; Perrucchini G; Scotto G; Parafioriti A; Zerbi A; Sconfienza LM
    J Magn Reson Imaging; 2018 Apr; 47(4):1034-1042. PubMed ID: 28755383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted Biopsy Validation of Peripheral Zone Prostate Cancer Characterization With Magnetic Resonance Fingerprinting and Diffusion Mapping.
    Panda A; OʼConnor G; Lo WC; Jiang Y; Margevicius S; Schluchter M; Ponsky LE; Gulani V
    Invest Radiol; 2019 Aug; 54(8):485-493. PubMed ID: 30985480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of Gaussian and non-Gaussian diffusion models for differential diagnosis of prostate cancer with in-bore transrectal MR-guided biopsy as a pathological reference.
    Li C; Chen M; Wan B; Yu J; Liu M; Zhang W; Wang J
    Acta Radiol; 2018 Nov; 59(11):1395-1402. PubMed ID: 29486596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Combined MR Fingerprinting and Diffusion Examination for Prostate Cancer.
    Yu AC; Badve C; Ponsky LE; Pahwa S; Dastmalchian S; Rogers M; Jiang Y; Margevicius S; Schluchter M; Tabayoyong W; Abouassaly R; McGivney D; Griswold MA; Gulani V
    Radiology; 2017 Jun; 283(3):729-738. PubMed ID: 28187264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of noncancerous tissue and cancer lesions by apparent diffusion coefficient values in transition and peripheral zones of the prostate.
    Sato C; Naganawa S; Nakamura T; Kumada H; Miura S; Takizawa O; Ishigaki T
    J Magn Reson Imaging; 2005 Mar; 21(3):258-62. PubMed ID: 15723379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate MRI: diffusion-weighted imaging at 1.5T correlates better with prostatectomy Gleason Grades than TRUS-guided biopsies in peripheral zone tumours.
    Bittencourt LK; Barentsz JO; de Miranda LC; Gasparetto EL
    Eur Radiol; 2012 Feb; 22(2):468-75. PubMed ID: 21913058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differentiation of prostate cancer lesions in the Transition Zone by diffusion-weighted MRI.
    Bao J; Wang X; Hu C; Hou J; Dong F; Guo L
    Eur J Radiol Open; 2017; 4():123-128. PubMed ID: 29034282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Utility of Diffusion-Weighted Imaging and Perfusion Magnetic Resonance Imaging Parameters for Detecting Clinically Significant Prostate Cancer.
    Cindil E; Oner Y; Sendur HN; Ozdemir H; Gazel E; Tunc L; Cerit MN
    Can Assoc Radiol J; 2019 Nov; 70(4):441-451. PubMed ID: 31561925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T2* relaxation time in the detection and assessment of aggressiveness of peripheral zone cancer in comparison with diffusion-weighted imaging.
    Wu LM; Zhou B; Lu Q; Suo ST; Liu Q; Hu J; Haccke EM; Chen XX; Xu JR
    Clin Radiol; 2016 Apr; 71(4):356-62. PubMed ID: 26823021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of intravoxel-incoherent motion diffusion-weighted imaging derived hypoxia for the risk stratification of prostate cancer in peripheral zone.
    Chen Z; Xue Y; Zhang Z; Li W; Wen M; Zhao Y; Li J; Weng Z; Ye Q
    Eur J Radiol; 2020 Apr; 125():108865. PubMed ID: 32058895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness.
    Vargas HA; Akin O; Franiel T; Mazaheri Y; Zheng J; Moskowitz C; Udo K; Eastham J; Hricak H
    Radiology; 2011 Jun; 259(3):775-84. PubMed ID: 21436085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.